Cape Healthcare and LPL Trustee each hold a 30.4 per cent stake in Pharmacybrands and based on the company paying a similar dividend over the next five years, could potentially increase their respective stakes to 35.1 per cent.
The dominant shareholders came out of a 2009 deal when NZX-listed Life Pharmacy, whose brands included Life Pharmacy, Life Metro and Care Chemist, made a $20 million all-scrip offer for Pharmacybrands, the country's then-biggest retail pharmacy group with the Amcal and Unichem brands.
Pharmacybrands' board declared a first-half dividend of 2 cents per share.
Chief executive Alan Wham said the company has been investing in information technology infrastructure to consolidate its e-commerce platforms, and plans to target customers based on their purchasing history.
"This will allow the company to increase the electronic component of its marketing mix over time," he said.
The retail trading environment is still tough, and same-store sales edged lower in the period, Wham said.
"We expect to see the focus placed on cost control to flow through in the form of savings in the second half," he said.